glp-1 therapy clinic American drugmakers pushed GLP1 therapies beyond diabetes into heart brain and liver care. These drugs started as blood sugar tools, then exploded into obesity treatment, and now they are being studied like Medical Weight Loss & Hormone

An adult Gila monster can consume all the energy it needs to survive a full year underground in just three to four meals

Obesity GLP-1 Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035 Industry Size (2025): USD 8,169 Mn Forecast (2035): USD 65,364 Mn CAGR (2025 to 2035): 23.1% Obesity GLP-1 Market Forecast and Outlook 2025 to 2035 The obesity GLP-1 market is projected to grow from USD 8169 million in 2025 to approximately USD 65,364 million by 2035, recording an absolute increase of USD 57,195 million over the forecast period

The FAP protein is highly expressed in epithelial cancers, playing a role in extracellular matrix remodeling, tumor growth, and metastasis

These medications have shown positive outcomes in dyslipidemia with much of the impact being on triglycerides

If youre currently using GLP-1 weight loss medications , share your experience in the comments below

The role of GLP-1R in AD is reflected mainly in the following aspects: it can decrease A deposition and inhibit tau protein hyperphosphorylation, reduce neuroinflammation and oxidative stress (OS) (Du et al., 2022)